GUYASUTA INVESTMENT ADVISORS INC - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 90 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUYASUTA INVESTMENT ADVISORS INC ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$7,000
-66.7%
18,5400.0%0.00%
-66.7%
Q4 2015$21,000
+50.0%
18,540
+27.5%
0.00%
+50.0%
Q3 2015$14,000
-26.3%
14,5400.0%0.00%
-33.3%
Q2 2015$19,0000.0%14,5400.0%0.00%0.0%
Q1 2015$19,000
-5.0%
14,5400.0%0.00%0.0%
Q4 2014$20,000
+5.3%
14,5400.0%0.00%0.0%
Q3 2014$19,000
-29.6%
14,5400.0%0.00%
-25.0%
Q2 2014$27,0000.0%14,5400.0%0.00%0.0%
Q1 2014$27,000
+35.0%
14,5400.0%0.00%
+33.3%
Q4 2013$20,0000.0%14,5400.0%0.00%0.0%
Q3 2013$20,000
+11.1%
14,5400.0%0.00%0.0%
Q2 2013$18,00014,5400.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
BAXTER BROS INC 170,506$232,0000.09%
First Heartland Consultants, Inc. 86,204$117,0000.05%
Rotella Capital Management, Inc. 20,769$28,0000.03%
FIDGEON TIMOTHY F 33,000$45,0000.02%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 547,800$746,0000.02%
Freedom Investment Management, Inc. 74,127$101,0000.02%
Investors Capital Advisory Services 63,288$86,0000.02%
REYNOLDS CAPITAL MANAGEMENT LLC 10,000$14,0000.01%
Tower Research Capital LLC (TRC) 76,914$104,0000.01%
PINNACLE FINANCIAL PARTNERS INC 20,000$27,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders